Core Scientific (CORZ) Cash from Investing Activities (2021 - 2026)

Core Scientific has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$796.2 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 565.71% year-over-year to -$796.2 million; the TTM figure through Jun 2026 stood at -$1.7 billion (down 538.35% YoY), while the FY2025 annual figure was -$740.8 million, down 678.16% from the prior year.
• Cash from Investing Activities came in at -$796.2 million for Q2 2026 at Core Scientific, down from -$386.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q4 2023 to a low of -$796.2 million in Q2 2026.
• Average Cash from Investing Activities over 5 years is -$145.1 million, with a median of -$60.5 million recorded in 2024.
• Year-over-year, Cash from Investing Activities soared 101.69% in 2023 and tumbled 3656.53% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$139.5 million in 2022, then soared by 101.69% to $2.4 million in 2023, then sank by 1320.25% to -$28.8 million in 2024, then sank by 864.54% to -$277.8 million in 2025, then slumped by 186.66% to -$796.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$796.2 million in Q2 2026, -$386.7 million in Q1 2026, and -$277.8 million in Q4 2025.